Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Artrya Limited ( (AU:AYA) ) has provided an announcement.
Artrya Limited has announced the quotation of 7,175,588 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 31, 2025. This move is part of a previously announced transaction, which may enhance the company’s liquidity and market presence, potentially benefiting stakeholders by increasing the company’s visibility and trading activity.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical technologies. The company specializes in creating innovative solutions for the diagnosis and management of heart disease, aiming to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 872,395
Technical Sentiment Signal: Buy
Current Market Cap: A$496.2M
For an in-depth examination of AYA stock, go to TipRanks’ Overview page.